Trade Mark Journal No.2026/010 6 March 2026

UK00004341198 16 February 2026 (5,42)

NEUROSHUTTLE

International priority date claimed: 29 August 2025 (United States of America) (99365820)

Class 5: Drug delivery agents comprising compounds that facilitate delivery of a wide range of pharmaceuticals and therapeutics; Drug delivery agents comprising biological preparations in the nature of non-viral platforms that facilitate delivery of a wide range of pharmaceuticals and biotherapeutics for treatment of diseases and disorders.
Class 42: Biotechnology research services; research and development of platform technologies for delivery of therapies and pharmaceuticals; research and development for the delivery of therapeutics; research and development regarding delivery of therapeutics.

Voyager Therapeutics, Inc.

Representative: Laytons LLP